Role of pyroptosis in bilirubin-induced microglial injury
HUANG Hong-Mei, HE Chun-Mei, LI Si-Yu, ZHANG Yan, HUA Zi-Yu
Department of Neonatology, Children's Hospital of Chongqing Medical University/Ministry of Education Key Laboratory of Child Development and Disorders/National Clinical Research Center for Child Health and Disorders/China International Science and Technology Cooperation Base of Child Development and Critical Disorders/Chongqing Key Laboratory of Child Infection and Immunity, Chongqing 400013, China
Abstract：Objective To study whether pyroptosis is involved in the bilirubin-induced injury of primary cultured rat cortical microglial cells. Methods Primary cultured rat cortical microglial cells were randomly administered with 30 μmol/L bilirubin (bilirubin group), 30 μmol/L bilirubin following 30 μmol/L VX-765 pretreatment (VX-765+bilirubin group), or an equal volume of dimethyl sulfoxide (control group). Modified MTT assay was used to measure the viability of microglial cells. Western blot was used to measure the expression of the pyroptosis-related proteins Caspase-1 and gasdermin D (GSDMD). Lactate dehydrogenase (LDH)-release assay was used to evaluate the cytotoxicity of microglial cells. EtBr/EthD2 with different molecular weights (394 Da/1 293 Da) was used to measure the size of plasma membrane pores. ELISA was used to measure the level of the inflammatory factor interleukin-1β (IL-1β) in culture supernatant. Results After bilirubin stimulation, the viability of microglial cells decreased and LDH release increased, both in a time-dependent manner. Compared with the control group, the bilirubin group had a significantly higher positive rate of small-molecule EtBr passing through the cell membrane (P < 0.001), while there was no significant difference in the pass rate of large-molecule EthD2 between groups (P > 0.05). The expression of activated Caspase-1 significantly increased at 0.5 hour after bilirubin stimulation (P < 0.05), and that of activated GSDMD significantly increased at 6 hours after bilirubin stimulation (P < 0.05). The release of IL-1β significantly increased at 6 hours after bilirubin stimulation and reached the peak at 24 hours (P < 0.001). Compared with the bilirubin group, the VX-765+bilirubin group had a significant increase in cell viability (P < 0.05) and significant reductions in the expression of activated GSDMD, the pass rate of EtBr, and the release of LDH and IL-1β (P < 0.05). Conclusions Pyroptosis is involved in bilirubin-induced injury of primary cultured microglial cells.
Schiavon E, Smalley JL, Newton S, et al. Neuroinflammation and ER-stress are key mechanisms of acute bilirubin toxicity and hearing loss in a mouse model[J]. PLoS One, 2018, 13(8):e0201022.
[2]
Memon N, Weinberger BI, Hegyi T, et al. Inherited disorders of bilirubin clearance[J]. Pediatr Res, 2016, 79(3):378-386.
[3]
Brites D. The evolving landscape of neurotoxicity by unconjugated bilirubin:role of glial cells and inflammation[J]. Front Pharmacol, 2012, 3:88.
[4]
Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage-mechanisms and management approaches[J]. N Engl J Med, 2013, 369(21):2021-2030.
[5]
Vodret S, Bortolussi G, Iaconcig A, et al. Attenuation of neuro-inflammation improves survival and neurodegeneration in a mouse model of severe neonatal hyperbilirubinemia[J]. Brain Behav Immun, 2018, 70:166-178.
Rose J, Vassar R. Movement disorders due to bilirubin toxicity[J]. Semin Fetal Neonatal Med, 2015, 20(1):20-25.
[8]
Barateiro A, Chen S, Yueh MF, et al. Reduced myelination and increased glia reactivity resulting from severe neonatal hyperbilirubinemia[J]. Mol Pharmacol, 2016, 89(1):84-93.
[9]
Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J]. Nature, 2015, 526(7575):660-665.
[10]
Fink SL, Cookson BT. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages[J]. Cell Microbiol, 2006, 8(11):1812-1825.
[11]
McKenzie BA, Mamik MK, Saito LB, et al. Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis[J]. Proc Natl Acad Sci U S A, 2018, 115(26):E6065-E6074.
[12]
Flores J, Noël A, Foveau B, et al. Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model[J]. Nat Commun, 2018, 9(1):3916.
[13]
Feng J, Li M, Wei Q, et al. Unconjugated bilirubin induces pyroptosis in cultured rat cortical astrocytes[J]. J Neuroin-flammation, 2018, 15(1):23.
[14]
Perry VH, Holmes C. Microglial priming in neurodegenerative disease[J]. Nat Rev Neurol, 2014, 10(4):217-224.
[15]
Brites D, Fernandes A, Falcão AS, et al. Biological risks for neurological abnormalities associated with hyperbiliru-binemia[J]. J Perinatol, 2009, 29 Suppl 1:S8-S13.
[16]
Jacque CM, Vinner C, Kujas M, et al. Determination of glial fibrillary acidic protein (GFAP) in human brain tumors[J]. J Neurol Sci, 1978, 35(1):147-155.
[17]
Tamashiro TT, Dalgard CL, Byrnes KR. Primary microglia isolation from mixed glial cell cultures of neonatal rat brain tissue[J]. J Vis Exp, 2012, (66):e3814.
[18]
Watchko JF. Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns[J]. Neuromolecular Med, 2006, 8(4):513-529.
[19]
He C, Feng J, Huang H, et al. Caspase-1 involves in bilirubin-induced injury of cultured rat cortical neurons[J]. Pediatr Res, 2019, 86(4):492-499.
[20]
Hanisch UK. Microglia as a source and target of cytokines[J]. Glia, 2002, 40(2):140-155.
[21]
Conde JR, Streit WJ. Microglia in the aging brain[J]. J Neuropathol Exp Neurol, 2006, 65(3):199-203.
[22]
Man SM, Kanneganti TD. Converging roles of caspases in inflammasome activation, cell death and innate immunity[J]. Nat Rev Immunol, 2016, 16(1):7-21.
Lv Y, Sun B, Lu XX, et al. The role of microglia mediated pyroptosis in neonatal hypoxic-ischemic brain damage[J]. Biochem Biophys Res Commun, 2020, 521(4):933-938.
[25]
He X, Yang W, Zeng Z, et al. NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology[J]. Cell Mol Immunol, 2020, 17(3):283-299.
[26]
Paré A, Mailhot B, Lévesque SA, et al. IL-1β enables CNS access to CCR2hi monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells[J]. Proc Natl Acad Sci U S A, 2018, 115(6):E1194-E1203.
[27]
Meissner F, Molawi K, Zychlinsky A. Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis[J]. Proc Natl Acad Sci U S A, 2010, 107(29):13046-13050.
[28]
Evavold CL, Ruan J, Tan Y, et al. The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages[J]. Immunity, 2018, 48(1):35-44.e6.
[29]
Maroso M, Balosso S, Ravizza T, et al. Interleukin-1β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice[J]. Neurotherapeutics, 2011, 8(2):304-315.
[30]
Li Q, Dai Z, Cao Y, et al. Caspase-1 inhibition mediates neuroprotection in experimental stroke by polarizing M2 microglia/macrophage and suppressing NF-κB activation[J]. Biochem Biophys Res Commun, 2019, 513(2):479-485.
[31]
Xu XE, Liu L, Wang YC, et al. Caspase-1 inhibitor exerts brain-protective effects against sepsis-associated encephalopathy and cognitive impairments in a mouse model of sepsis[J]. Brain Behav Immun, 2019, 80:859-870.
